Marengo Therapeutics Announces Clinical Study Collaboration with Gilead ... - PR Newswire
Marengo Therapeutics and Gilead collaborate on a Phase I/II study combining STAR0602 (Invikafusp alfa) with Trodelvy for metastatic HR+/HER2- breast cancer and TNBC, aiming to explore a novel therapeutic strategy.
Related Clinical Trials
Reference News
Marengo Therapeutics Announces Clinical Study Collaboration with Gilead ... - PR Newswire
Marengo Therapeutics and Gilead collaborate on a Phase I/II study combining STAR0602 (Invikafusp alfa) with Trodelvy for metastatic HR+/HER2- breast cancer and TNBC, aiming to explore a novel therapeutic strategy.